archyworldys

Research indicates some omikron variants Avoid antibodies from the Sinofarm vaccine.

REUTERS

Research indicates some omikron variants Avoid antibodies from the Sinofarm vaccine.

A small Chinese study published in the Lancet Medical Journal found that Most omikron mutant coronavirus variants The antibodies of those vaccinated against the two Sinofarm vaccines were able to dodge the antibodies, while booster vaccinations only partially restored their resistance to omikron.

The study, which followed data from a sample of 25 subjects who received two doses of Sinofarm’s coronavirus vaccine or BBIBP-CorV vaccine, was able to manage the omicron variant BA.2.12.1 BA. .4 and BA.5 only slightly. or accounted for only 24-48% of those who received 2 doses of vaccine.

Among those who received a third dose of booster vaccine from Chongqing Zhifei Biology Co., another vaccine approved for use in China, The ratio of resistance to subspecies of omikron was slightly increased to 30-53% from another sample of 30 participants.

However, the study did not determine the effectiveness of the booster vaccine as an indicator of how well it reduces the risk of death or contracting COVID-19, based on large-scale clinical trials.

Sino Farm’s anti-coronavirus vaccine, or BBIBP-CorV vaccine, is one of two vaccines approved for use in China. It is also the main vaccine owned by the Chinese government company. Including also exporting to various countries China continues to approve the use of self-developed vaccines. and still adhere to the zero-covid policy As many countries have turned to coexistence with the virus policy

Read also  Rachel Levine: Transgender officer sworn in as US four-star general-BBC News

Trending